Marc Bonaca MD MPH (@marcbonaca) 's Twitter Profile
Marc Bonaca MD MPH

@marcbonaca

Cardiology and Vascular Medicine Specialist. Executive Director of CPC Clinical Research. Director of Vascular Research. University of Colorado.

ID: 1028017360295288832

linkhttps://cpcclinicalresearch.org calendar_today10-08-2018 20:36:53

324 Tweet

1,1K Followers

1,1K Following

cardio-met (@cardiomet_ce) 's Twitter Profile Photo

You have found it! Your source for free CE/CME via Twitter! Each program provides 0.5h credit for #physicians, #pharmacists, and #nurses on topics of interest in the cardiometabolic space. Expert authors! See archived programs (and still earn credit) at cardiometabolic-ce.com.

Daniella KadianDodov (@dkadiandodov) 's Twitter Profile Photo

Super excited about the multispecialty faculty (VS, IR, IC, VM) - all passionate about education! Whether you want to set yourself up for success in managing your vascular patients or simply win vascular jeopardy, we are ready for you! Travel stipend for 1st time attendees 😎

Andrew J Sauer MD (@andrewjsauer) 's Twitter Profile Photo

Saint Luke's Mid America Heart Institute is proud to announce we randomized first patient in REDEFINE-HF, an international, randomized, placebo-controlled, event-driven trial of finerenone for the treatment hospitalized heart failure patients with HFmrEF/HFpEF. classic.clinicaltrials.gov/ct2/show/NCT06…

<a href="/MidAmericaHeart/">Saint Luke's Mid America Heart Institute</a> is proud to announce we randomized first patient in REDEFINE-HF, an international, randomized, placebo-controlled, event-driven trial of finerenone for the treatment hospitalized heart failure patients with HFmrEF/HFpEF.

classic.clinicaltrials.gov/ct2/show/NCT06…
CPC Clinical Research (@cpcresearch) 's Twitter Profile Photo

Next stop 🛑 in B309 is Kevin Rogers presenting - Risk of Adverse Events in Peripheral Artery Disease Patients with Below-Knee Disease: An Analysis from the VOYAGER-PAD Catheter-Based Angiographic Core Lab at 8:49 AM ET! 🚂🚃

Marc Bonaca MD MPH (@marcbonaca) 's Twitter Profile Photo

Connie Hess shows new data from VOYAGER PAD on the efficacy and safety of DAPT after endovascular lower extremity revascularization! #ACC2024 #ACC24

Connie Hess shows new data from VOYAGER PAD on the efficacy and safety of DAPT after endovascular lower extremity revascularization! #ACC2024 #ACC24
Marc Bonaca MD MPH (@marcbonaca) 's Twitter Profile Photo

Major adverse limb events higher in patients with below knee disease - results from the VOYAGER PAD Angiographic Core Lab #ACC2024 #ACC24

Major adverse limb events higher in patients with below knee disease - results from the VOYAGER PAD Angiographic Core Lab #ACC2024 #ACC24
Marc Bonaca MD MPH (@marcbonaca) 's Twitter Profile Photo

Predicting amputation in PAD - Adding patient comorbidity / diabetes improves risk stratification - should WIFI be DM-WIFI? #ACC2024 #ACC24

Predicting amputation in PAD -
Adding patient comorbidity / diabetes improves risk stratification - should WIFI be DM-WIFI? #ACC2024 #ACC24
ACC Media Center (@accmediacenter) 's Twitter Profile Photo

We just wrapped our final press conference for #ACC24! ✅ A big thank you to discussants Dr. Marc Bonaca MD MPH, Dr. @jennifer_rymer and Kim Guibone DNP, APRN, FACC, DNP, for their excellent remarks to close out the press program.

We just wrapped our final press conference for #ACC24! ✅  A big thank you to discussants Dr. <a href="/MarcBonaca/">Marc Bonaca MD MPH</a>, Dr. @jennifer_rymer and <a href="/kim_guibone/">Kim Guibone DNP, APRN, FACC</a>, DNP, for their excellent remarks to close out the press program.
Mario Enrico Canonico (@me_canonico) 's Twitter Profile Photo

Our analysis from VOYAGER-PAD trial published in Circulation. New data on Rivaroxaban plus Aspirin in PAD+CAD patients undergoing LER. Thanks to EC Members and Co-Authors! #VascularMedicine Marc Bonaca MD MPH CPC Clinical Research CU Department of Medicine CU Cardiology. ahajournals.org/doi/10.1161/CI…

Our analysis from VOYAGER-PAD trial published in <a href="/CircAHA/">Circulation</a>. New data on Rivaroxaban plus Aspirin in PAD+CAD patients undergoing LER. Thanks to EC Members and Co-Authors! #VascularMedicine 
<a href="/MarcBonaca/">Marc Bonaca MD MPH</a> <a href="/cpcresearch/">CPC Clinical Research</a> <a href="/CUDeptMedicine/">CU Department of Medicine</a> <a href="/CUCardiology/">CU Cardiology</a>.

ahajournals.org/doi/10.1161/CI…
JACC Journals (@jaccjournals) 's Twitter Profile Photo

🌟 2023 Impact Factors are in! The #JACCJournals portfolio remains the strongest among the major cardiovascular portfolios of peer reviewed journals. All eligible JACC Journals ranked in the top 18. More: bit.ly/2OvgHq7 #Cardiology

🌟 2023 Impact Factors are in! The #JACCJournals portfolio remains the strongest among the major cardiovascular portfolios of peer reviewed journals. All eligible JACC Journals ranked in the top 18. 
More: bit.ly/2OvgHq7 #Cardiology
CU Cardiology (@cucardiology) 's Twitter Profile Photo

The American Journal of Managed Care, Colorado Prevention Center, & the University of Colorado, present: Institute for Value-Based Medicine, Population Health Lipid Risk Management Forum & Dinner, Chaired by Dr. Marc Bonaca! More info/to register: event.ajmc.com/event/IVBMAugu…

The American Journal of Managed Care, Colorado Prevention Center, &amp; the University of Colorado, present: Institute for Value-Based Medicine, Population Health Lipid Risk Management Forum &amp; Dinner,
Chaired by  Dr. Marc Bonaca! More info/to register: event.ajmc.com/event/IVBMAugu…
JACC Journals (@jaccjournals) 's Twitter Profile Photo

What is #JACC about? Listen as Editor-in-Chief Dr. Harlan Krumholz details why JACC is focused on impact 💥 and ensuring the future of cardiovascular health around the globe 🌎 is better than the past. Watch ⬇️ & learn more here: bit.ly/3VTRAh2 Harlan Krumholz